Rachel Chancy Shue, | |
2301 Crownpoint Executive Dr, Suite E, Charlotte, NC 28227-7824 | |
(704) 708-8314 | |
(704) 708-8315 |
Full Name | Rachel Chancy Shue |
---|---|
Gender | Female |
Speciality | Behavior Analyst |
Location | 2301 Crownpoint Executive Dr, Charlotte, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023287240 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 7187 (North Carolina) | Secondary |
103K00000X | Behavior Analyst | 11520604 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rachel Chancy Shue, 2301 Crownpoint Executive Dr, Suite E, Charlotte, NC 28227-7824 Ph: (704) 708-8314 | Rachel Chancy Shue, 2301 Crownpoint Executive Dr, Suite E, Charlotte, NC 28227-7824 Ph: (704) 708-8314 |
News Archive
Researchers believe they have solved a mystery that has puzzled evolutionary scientists for years ... if 'good' genes spread through the population, why are individuals so different?
Melbourne researchers have come up with new "smart bandage" that changes colour depending on the temperature of the skin beneath, giving health professionals a powerful new tool for treating wounds and monitoring possible infections.
Although a link has been established between chronic inflammation and neurodegenerative diseases, there have been many open questions regarding how cellular senescence, a process whereby cells that stop dividing under stress spew out a mix of inflammatory proteins, affects these pathologies.
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center report that bariatric surgery resulting in dramatic weight loss in formerly severely obese women reduces the risk of endometrial (uterine) cancer by 71 percent and as much as 81 percent if normal weight is maintained after surgery.
In the years since the birth of the first ‘test-tube' baby in 1978, in-vitro fertilisation (IVF) has grown to become an accepted mainstream medical technique, with more than 25,000 treatments carried out every year.
› Verified 5 days ago